Priority Date: 02.07.12 (US 201261666981P)

THERAPEUTIC AGENT FOR ANEMIA INCLUDING RENAL ANEMIA AND CANCER-INDUCED ANEMIA WHICH CONTAINS ANTI-BMP9 ANTIBODY AS ACTIVE INGREDIENT

  • Application ID: EP13812775
  • Status: EXAMINATION IN PROGRESS

Attorneys

no operation time available
1115.57
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing
no operation time available
1115.57
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination C07 (ORGANIC CHEMISTRY) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) J A Kemp is specialized in the combination C07 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 141 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 02.07.2012 - Priority Date (US 201261666981P)
  • 09.01.2014 - Publication A1 (WO2014007198)
  • 06.05.2015 - Publication A1 (EP2868667)